Inventor · disambiguated record
Steven Howard
Also filed as: HOWARD STEVEN · HOWARD STEVEN P
37 granted patents·20 pending applications·309 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
57 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0295US9458158B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 4, 2016·11 cites·22 claims
- 0394US8685980B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT EBAI·Filed 2009·Granted Apr 1, 2014·81 cites·15 claims
- 0493US11225476B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 18, 2022·3 cites·13 claims
- 0592US11866428B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0692US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0792US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0892US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0992US9617248B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 1091US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 1191US9980973B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted May 29, 2018·6 cites·21 claims
- 1291US9783538B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 10, 2017·12 cites·53 claims
- 1391US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 1490US11643410B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2021·Granted May 9, 2023·1 cites·22 claims
- 1590US9676768B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Jun 13, 2017·8 cites·16 claims
- 1690US9155743B2Bicyclic heterocycle compounds and their uses in therapyBUCK ILDIKO MARIA·Filed 2012·Granted Oct 13, 2015·12 cites·18 claims
- 1790US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 1889US2025296930A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1987US10618895B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted Apr 14, 2020·4 cites·33 claims
- 2087US9018214B2Bicyclic heterocycle compounds and their uses in therapyWOOLFORD ALISON JO-ANNE·Filed 2012·Granted Apr 28, 2015·13 cites·21 claims
- 2186US9617283B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 2286US7056491B2Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulatorsWISCONSIN ALUMNI RES FOUND·Filed 2001·Granted Jun 6, 2006·25 cites·20 claims
- 2385US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 2485US2024199607A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2584US12202828B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·48 claims
- 2684US12077526B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2023·Granted Sep 3, 2024·1 cites·22 claims
- 2784US9663512B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·8 cites·18 claims
- 2884US9416136B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2014·Granted Aug 16, 2016·8 cites·23 claims
- 2983US12037345B2Heterobicyclic compounds for inhibiting the activity of SHP2TAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 16, 2024·2 cites·19 claims
- 3083US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 3182US2024043428A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3282US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 3382US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 3479US11603367B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2018·Granted Mar 14, 2023·2 cites·12 claims
- 3579US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 3673US2021253578A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3772US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 3872US6878704B2Heterocyclic mutilin esters and their use as antibacterialsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Apr 12, 2005·8 cites·20 claims
- 3970US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 4070US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 4167US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4267US2019375748A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4364US2018155351A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 4463US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 4563US6972297B22-Hydroxy-mutilin carbamate derivatives for antibacterial useSMITHKLINE BEECHAM PLC·Filed 2001·Granted Dec 6, 2005·2 cites·9 claims
- 4661US2017334907A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 4756US2024262842A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4856US2017183352A1Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2016·Application pending·0 cites
- 4955US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 5054US2024239788A1Small molecule inhibitors of kras g12d mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven Howard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →